Substance Abuse Emergencies

  • Hiromichi NaitoEmail author
  • Tetsuya Yumoto
  • Clifton W Callaway


Substance abuse is a major clinical problem in emergency care. Rapid physiological evaluation and identification of responsible drugs can improve treatment. Abused substances are categorized by similarities in their effects. However, even within the same category, each substance may have its own unique characteristics. Supportive care plays the major role for most patients, although some patients need chemical absorption, enhanced elimination, or use of specific antidotes. It is necessary for clinicians to have ability to recognize clinical signs of various abused substances in order to treat patients in emergent conditions.


Illegal Addiction Drug Intoxication Overdose 


  1. Ball IM, Linden CH (2011) Pharmacology, overdoses, and poisonings. In: Irwin RS, Rippe JM (eds) Irwin & Rippe’s intensive care medicine, 7th edn. Lippincott Williams & Wilkins, Philadelphia, p 1314Google Scholar
  2. Byatt C, Volans G (1984) ABC of poisoning. Sedative and hypnotic drugs. Br Med J 289:1214–1217CrossRefGoogle Scholar
  3. Callaway CW, Clark RF (1994) Hypothermia in psychostimulant overdose. Ann Emerg Med 24:68–76CrossRefGoogle Scholar
  4. Chaudhuri C, Salahudeen AK (1999) Massive intracerebral hemorrhage in an amphetamine addict. Am J Med Sci 317:350–352CrossRefGoogle Scholar
  5. Degenhardt L, Whiteford HA, Ferrari AJ, Baxter AJ, Charlson FJ, Hall WD, Freedman G, Burstein R, Johns N, Engell RE, Flaxman A, Murray CJ, Vos T (2013) Global burden of disease attributable to illicit drug use and dependence: findings from the global burden of disease study 2010. Lancet 382:1564–1574CrossRefGoogle Scholar
  6. Devlin RJ, Henry JA (2008) Clinical review: major consequences of illicit drug consumption. Crit Care 12:202CrossRefGoogle Scholar
  7. Höjer J, Troutman WG, Hoppu K, Erdman A, Benson BE, Mégarbane B, Thanacoody R, Bedry R, Caravati EM (2013) Position paper update: ipecac syrup for gastrointestinal decontamination. Clin Toxicol (Phila) 51:134–139CrossRefGoogle Scholar
  8. Hollander JE (1995) The management of cocaine-associated myocardial ischemia. N Engl J Med 333:1267–1272CrossRefGoogle Scholar
  9. Isbister GK, Downes F, Sibbritt D, Dawson AH, Whyte IM (2004) Aspiration pneumonitis in an overdose population: frequency, predictors, and outcomes. Crit Care Med 32:88–93CrossRefGoogle Scholar
  10. McCarron MM, Wood JD (1983) The cocaine body packer syndrome. JAMA 250:1417CrossRefGoogle Scholar
  11. Paul BD, Smith ML (1999) LSD–an overview on drug action and detection. Forensic Sci Rev 11:157–174PubMedGoogle Scholar
  12. Spivey WH (1992) Flumazenil and seizures: analysis of 43 cases. Clin Ther 14:292–305PubMedGoogle Scholar
  13. Thanacoody R, Caravati EM, Troutman B, Höjer J, Benson B, Hoppu K, Erdman A, Bedry R, Mégarbane B (2015) Position paper update: whole bowel irrigation for gastrointestinal decontamination of overdose patients. Clin Toxicol (Phila) 53:5–12CrossRefGoogle Scholar
  14. Watson WA, Litovitz TL, Klein-Schwartz W, Rodgers GC Jr, Youniss J, Reid N, Rouse WG, Rembert RS, Borys D (2003) 2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 22:335–404CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Hiromichi Naito
    • 1
    Email author
  • Tetsuya Yumoto
    • 2
  • Clifton W Callaway
    • 3
  1. 1.Department of Emergency Healthcare and Disaster MedicineOkayama University Graduate School of Medicine Dentistry and Pharmaceutical SciencesOkayamaJapan
  2. 2.Department of Emergency and Critical Care MedicineOkayama University Graduate School of Medicine Dentistry and Pharmaceutical SciencesOkayamaJapan
  3. 3.Department of Emergency MedicineUniversity of Pittsburgh School of MedicinePittsburghUSA

Personalised recommendations